LoginRegister
    Sanofi, Regeneron loses patent challenge to Amgen cholesterol drug RepathaSanofi, Regeneron loses patent challenge to Amgen cholesterol drug Repatha
    Diabetics, insuline providers stockpile over Brexit fearsDiabetics, insuline providers stockpile over Brexit fears
    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A FundingDesi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding
    Pharmaceutical residues in fresh water pose environmental riskPharmaceutical residues in fresh water pose environmental risk
    U.S. Senators launch bipartisan probe into rising insulin pricesU.S. Senators launch bipartisan probe into rising insulin prices
    AHPI inks MoU with AiMeD to promote Indian Medical Devices IndustryAHPI inks MoU with AiMeD to promote Indian Medical Devices Industry
    Launching product without Approval: DOP rejects Biocon Plea against NPPA actionLaunching product without Approval: DOP rejects Biocon Plea against NPPA action
    Kerala: Government MCHs faces acute shortage of pharmacistsKerala: Government MCHs faces acute shortage of pharmacists
    Novartis gene therapy for SMA to be cost effective up to $900000: US groupNovartis gene therapy for SMA to be cost effective up to $900000: US group
    Activist targets Bristol Myers in drug M&A trialsActivist targets Bristol Myers in drug M&A trials
    North Dakotas first medical marijuana dispensary set to openNorth Dakotas first medical marijuana dispensary set to open
    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X